CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-28 | Mendelson Daniel Newman Director | Purchase | +5,000 | $6.22 | $31K | 169,581 |
| 2023-09-27 | Mendelson Daniel Newman Director | Purchase | +1,500 | $5.95 | $9K | 164,581 |
| 2023-09-26 | Mendelson Daniel Newman Director | Purchase | +5,000 | $5.65 | $28K | 145,951 |
| 2023-09-22 | Mendelson Daniel Newman Director | Purchase | +3,812 | $5.50 | $21K | 140,951 |
| 2023-09-21 | Mendelson Daniel Newman Director | Purchase | +5,000 | $5.51 | $28K | 137,139 |
| 2023-09-20 | Mendelson Daniel Newman Director | Purchase | +4,018 | $5.51 | $22K | 132,139 |
| 2023-09-19 | Mendelson Daniel Newman Director | Purchase | +5,000 | $5.28 | $26K | 128,121 |
| 2023-03-17 | Morris Ronnie CEO | Purchase | +12,382 | $4.04 | $50K | 858,878 |
| 2022-11-01 | Brainin Robert Lawrence Director | Grant or award · Option to purchase Common Stock | +14,130 | $7.00 | $99K | 32,063 |
| 2022-11-01 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +26,500 | $7.00 | $186K | 26,500 |
| 2022-11-01 | Breitfeld Philip P. Director | Grant or award · Option to purchase Common Stock | +11,480 | $7.00 | $80K | 11,480 |
| 2022-11-01 | Mendelson Daniel Newman Director | Grant or award · Option to purchase Common Stock | +19,430 | $7.00 | $136K | 19,430 |
| 2022-11-01 | SIDRANSKY DAVID Director | Grant or award · Option to purchase Common Stock | +11,480 | $7.00 | $80K | 11,480 |
| 2022-11-01 | TOBIN SCOTT R Director | Grant or award · Option to purchase Common Stock | +21,200 | $7.00 | $148K | 21,200 |
| 2022-10-19 | ACKERMAN JOEL Director | Option exercise | +16,667 | $3.21 | $54K | 1,460,595 |
| 2022-10-19 | ACKERMAN JOEL Director | Option exercise · Option to purchase Common Stock | +16,667 | 0 | ||
| 2022-10-12 | SIDRANSKY DAVID Director | Option exercise | +8,333 | $3.21 | $27K | 770,605 |
| 2022-10-12 | SIDRANSKY DAVID Director | Shares withheld for taxes | −3,562 | $7.51 | $27K | 767,043 |
| 2022-10-12 | SIDRANSKY DAVID Director | Option exercise · Option to purchase Common Stock | −8,333 | 0 | ||
| 2022-10-12 | Breitfeld Philip P. Director | Option exercise | +8,333 | $3.21 | $27K | 18,200 |
Page 4 of 20 · 398 trades